• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利缺血性心脏病患者经皮冠状动脉介入治疗的适宜性:APACHE 试点研究

APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study.

作者信息

Leonardi Sergio, Marino Marcello, Crimi Gabriele, Maiorana Florinda, Rizzotti Diego, Lettieri Corrado, Bettari Luca, Zuccari Marco, Sganzerla Paolo, Tresoldi Simone, Adamo Marianna, Ghiringhelli Sergio, Sponzilli Carlo, Pasquetto Giampaolo, Pavei Andrea, Pedon Luigi, Bassan Luciano, Bollati Mario, Camisasca Paola, Trabattoni Daniela, Brancati Marta, Poli Arnaldo, Panciroli Claudio, Lettino Maddalena, Tarelli Giuseppe, Tarantini Giuseppe, De Luca Leonardo, Varbella Ferdinando, Musumeci Giuseppe, De Servi Stefano

机构信息

Coronary Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Cardiology, Ospedale Maggiore di Crema, Crema, Italy.

出版信息

BMJ Open. 2017 Sep 5;7(9):e016909. doi: 10.1136/bmjopen-2017-016909.

DOI:10.1136/bmjopen-2017-016909
PMID:28877948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5588962/
Abstract

OBJECTIVES

To first explore in Italy appropriateness of indication, adherence to guideline recommendations and mode of selection for coronary revascularisation.

DESIGN

Retrospective, pilot study.

SETTING

22 percutaneous coronary intervention (PCI)-performing hospitals (20 patients per site), 13 (59%) with on-site cardiac surgery.

PARTICIPANTS

440 patients who received PCI for stable coronary artery disease (CAD) or non-ST elevation acute coronary syndrome were independently selected in a 4:1 ratio with half diabetics.

PRIMARY AND SECONDARY OUTCOME MEASURES

Proportion of patients who received appropriate PCI using validated appropriate use scores (ie, AUS≥7). Also, in patients with stable CAD, we examined adherence to the following European Society of Cardiology recommendations: (A) per cent of patients with complex coronary anatomy treated after heart team discussion; (B) per cent of fractional flow reserve-guided PCI for borderline stenoses in patients without documented ischaemia; (C) per cent of patients receiving guideline-directed medical therapy at the time of PCI as well as use of provocative test of ischaemia according to pretest probability (PTP) of CAD.

RESULTS

Of the 401 mappable PCIs (91%), 38.7% (95% CI 33.9 to 43.6) were classified as appropriate, 47.6% (95% CI 42.7 to 52.6) as uncertain and 13.7% (95% CI 10.5% to 17.5%) as inappropriate. Median PTP in patients with stable CAD without known coronary anatomy was 69% (78% intermediate PTP, 22% high PTP). Ischaemia testing use was similar (p=0.71) in patients with intermediate (n=140, 63%) and with high PTP (n=40, 66%). In patients with stable CAD (n=352) guideline adherence to the three recommendations explored was: (A) 11%; (B) 25%; (C) 23%. AUS was higher in patients evaluated by the heart team as compared with patients who were not (7 (6.8) vs 5 (4.7); p=0.001).

CONCLUSIONS

Use of heart team approaches and adherence to guideline recommendations on coronary revascularisation in a real-world setting is limited. This pilot study documents the feasibility of measuring appropriateness and guideline adherence in clinical practice and identifies substantial opportunities for quality improvement.

TRIAL REGISTRATION NUMBER

NCT02748603.

摘要

目的

首先在意大利探讨冠状动脉血运重建的适应症适宜性、对指南建议的遵循情况以及选择方式。

设计

回顾性试点研究。

地点

22家开展经皮冠状动脉介入治疗(PCI)的医院(每个地点20例患者),其中13家(59%)有现场心脏外科手术。

参与者

440例因稳定型冠状动脉疾病(CAD)或非ST段抬高型急性冠状动脉综合征接受PCI治疗的患者,按照4:1的比例独立选取,其中一半为糖尿病患者。

主要和次要结局指标

使用经过验证的适宜性评分(即AUS≥7)来确定接受适宜PCI治疗的患者比例。此外,对于稳定型CAD患者,我们检查了对以下欧洲心脏病学会建议的遵循情况:(A)心脏团队讨论后治疗的复杂冠状动脉解剖结构患者的百分比;(B)在无缺血记录的患者中,血流储备分数引导的PCI用于临界狭窄的百分比;(C)PCI时接受指南指导的药物治疗的患者百分比,以及根据CAD的预测试概率(PTP)进行缺血激发试验的使用情况。

结果

在401例可映射的PCI中(91%),38.7%(95%CI 33.9至43.6)被分类为适宜,47.6%(95%CI 42.7至52.6)为不确定,13.7%(95%CI 10.5%至17.5%)为不适宜。无已知冠状动脉解剖结构的稳定型CAD患者的中位PTP为69%(78%为中度PTP,22%为高度PTP)。中度PTP患者(n = 140,63%)和高度PTP患者(n = 40,66%)的缺血检测使用率相似(p = 0.71)。在稳定型CAD患者(n = 352)中,对所探讨的三项建议的指南遵循情况为:(A)11%;(B)25%;(C)23%。与未由心脏团队评估的患者相比,由心脏团队评估的患者的AUS更高(7(6.8)对5(4.7);p = 0.001)。

结论

在现实环境中,心脏团队方法的使用以及对冠状动脉血运重建指南建议的遵循情况有限。这项试点研究证明了在临床实践中测量适宜性和指南遵循情况的可行性,并确定了质量改进的大量机会。

试验注册号

NCT02748603。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/210a389013af/bmjopen-2017-016909f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/c3cfb13f8bc0/bmjopen-2017-016909f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/2fa959051e9d/bmjopen-2017-016909f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/210a389013af/bmjopen-2017-016909f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/c3cfb13f8bc0/bmjopen-2017-016909f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/2fa959051e9d/bmjopen-2017-016909f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2403/5588962/210a389013af/bmjopen-2017-016909f03.jpg

相似文献

1
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: the APACHE pilot study.意大利缺血性心脏病患者经皮冠状动脉介入治疗的适宜性:APACHE 试点研究
BMJ Open. 2017 Sep 5;7(9):e016909. doi: 10.1136/bmjopen-2017-016909.
2
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study.对于患有复杂疾病的稳定型患者,未实施冠状动脉血运重建指南建议与高比例的不完全血运重建相关:来自阿帕奇研究的分析。
Heart Vessels. 2020 Jan;35(1):30-37. doi: 10.1007/s00380-019-01459-1. Epub 2019 Jun 20.
3
Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease.欧洲心脏病学会和欧洲心胸外科学会指南对稳定型冠状动脉疾病血运重建策略的影响:经皮冠状动脉介入治疗和冠状动脉旁路移植术的活动变化。
J Thorac Cardiovasc Surg. 2014 Feb;147(2):606-10. doi: 10.1016/j.jtcvs.2013.01.026. Epub 2013 Feb 10.
4
Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015.2013 年至 2015 年美国退伍军人事务部医院中稳定型冠心病患者经皮冠状动脉介入治疗的适宜性。
JAMA Netw Open. 2020 Apr 1;3(4):e203144. doi: 10.1001/jamanetworkopen.2020.3144.
5
Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease.SYNTAX II试验的原理与设计:评估初发三支血管病变患者采用先进经皮冠状动脉血运重建术的短期至长期预后
EuroIntervention. 2016 Jun 12;12(2):e224-34. doi: 10.4244/EIJV12I2A36.
6
A pilot study on the application of the current European guidelines for the management of acute coronary syndrome without elevation of ST segment (NSTEMI) in the Emergency Department setting in the Italian region Lazio.一项关于在意大利拉齐奥地区急诊科应用当前欧洲非ST段抬高型急性冠状动脉综合征(NSTEMI)管理指南的试点研究。
Monaldi Arch Chest Dis. 2014 Dec;82(4):175-82. doi: 10.4081/monaldi.2014.61.
7
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.冠状动脉血运重建的合理使用标准以及经皮冠状动脉介入治疗的利用趋势、患者选择和适宜性
JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.
8
Measurement of fractional flow reserve in patients with multi-vessel coronary artery disease and borderline lesions prevents unnecessary revascularisation procedures.多支冠状动脉疾病合并临界病变患者的血流储备分数测量可避免不必要的血运重建手术。
Kardiol Pol. 2004 Apr;60(4):311-19; discussion 320-1.
9
[The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports].[欧洲心脏病学会(ESC)经皮冠状动脉介入治疗(PCI)指南。三例病例报告]
Herz. 2006 Dec;31(9):836-46, 848. doi: 10.1007/s00059-006-2939-y.
10
Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.经皮冠状动脉介入治疗与最佳药物治疗——硬币的另一面:药物依从性。
J Clin Pharm Ther. 2013 Dec;38(6):476-9. doi: 10.1111/jcpt.12091. Epub 2013 Aug 31.

引用本文的文献

1
Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease.多学科心脏团队指导下的复杂冠状动脉疾病管理后的长期生存情况。
Proc (Bayl Univ Med Cent). 2025 Jun 20;38(5):589-597. doi: 10.1080/08998280.2025.2516981. eCollection 2025.
2
Building and Optimizing the Interdisciplinary Heart Team.构建和优化跨学科心脏团队。
J Soc Cardiovasc Angiogr Interv. 2023 Jul 14;2(6Part A):101067. doi: 10.1016/j.jscai.2023.101067. eCollection 2023 Nov-Dec.
3
Treatment Adherence Rates and Long-Term Mortality in a Quaternary Multidisciplinary Heart Team: An Observational Cohort.

本文引用的文献

1
Avoiding overuse-the next quality frontier.避免过度使用——下一个质量前沿。
Lancet. 2017 Jul 8;390(10090):102-104. doi: 10.1016/S0140-6736(16)32570-3. Epub 2017 Jan 9.
2
Appropriate Use Criteria for Coronary Revascularization and Trends in Utilization, Patient Selection, and Appropriateness of Percutaneous Coronary Intervention.冠状动脉血运重建的合理使用标准以及经皮冠状动脉介入治疗的利用趋势、患者选择和适宜性
JAMA. 2015 Nov 17;314(19):2045-53. doi: 10.1001/jama.2015.13764.
3
Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.
四元多学科心脏团队治疗依从率与长期死亡率:一项观察性队列研究。
J Am Heart Assoc. 2024 Aug 20;13(16):e035097. doi: 10.1161/JAHA.124.035097. Epub 2024 Aug 9.
4
Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis.经皮冠状动脉介入治疗的适宜性:一项系统评价和荟萃分析。
J Cardiovasc Dev Dis. 2023 Feb 21;10(3):93. doi: 10.3390/jcdd10030093.
5
Methods for assessing guideline adherence for invasive procedures in the care of chronic coronary artery disease: a scoping review.评估慢性冠状动脉疾病治疗中侵袭性操作指南依从性的方法:范围综述。
BMJ Open. 2023 Mar 15;13(3):e069832. doi: 10.1136/bmjopen-2022-069832.
6
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study.对于患有复杂疾病的稳定型患者,未实施冠状动脉血运重建指南建议与高比例的不完全血运重建相关:来自阿帕奇研究的分析。
Heart Vessels. 2020 Jan;35(1):30-37. doi: 10.1007/s00380-019-01459-1. Epub 2019 Jun 20.
心脏团队冠状动脉血运重建方法及其对PCI术后临床事件的长期有益影响的描述。
Clin Res Cardiol. 2016 May;105(5):388-400. doi: 10.1007/s00392-015-0932-2. Epub 2015 Oct 27.
4
Outcomes of anatomical versus functional testing for coronary artery disease.冠状动脉疾病解剖学检测与功能检测的结果
N Engl J Med. 2015 Apr 2;372(14):1291-300. doi: 10.1056/NEJMoa1415516. Epub 2015 Mar 14.
5
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).2014年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南:欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组编写,欧洲经皮心血管介入协会(EAPCI)提供特别贡献。
Eur Heart J. 2014 Oct 1;35(37):2541-619. doi: 10.1093/eurheartj/ehu278. Epub 2014 Aug 29.
6
Major geographical variations in elective coronary revascularization by stents or surgery in England.英国通过支架或手术进行选择性冠状动脉血运重建的主要地理差异。
Eur J Cardiothorac Surg. 2015 May;47(5):855-9. doi: 10.1093/ejcts/ezu276. Epub 2014 Jul 17.
7
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance.美国心脏病学会/美国心脏协会/心血管造影和介入学会/美国医学协会召集的成人经皮冠状动脉介入治疗性能指标(2013年):美国心脏病学会/美国心脏协会性能指标特别工作组、心血管造影和介入学会、美国医学协会召集的医师绩效改进联合会以及国家质量保证委员会的报告
J Am Coll Cardiol. 2014 Feb 25;63(7):722-745. doi: 10.1016/j.jacc.2013.12.003. Epub 2013 Dec 19.
8
Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions.与不适当的经皮冠状动脉介入治疗相关的患者和医院特征。
J Am Coll Cardiol. 2013 Dec 17;62(24):2274-81. doi: 10.1016/j.jacc.2013.07.086. Epub 2013 Sep 18.
9
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.2013年欧洲心脏病学会稳定型冠状动脉疾病管理指南:欧洲心脏病学会稳定型冠状动脉疾病管理特别工作组
Eur Heart J. 2013 Oct;34(38):2949-3003. doi: 10.1093/eurheartj/eht296. Epub 2013 Aug 30.
10
Mortality in Medicare patients undergoing elective percutaneous coronary intervention with or without antecedent stress testing.接受选择性经皮冠状动脉介入治疗且有或无前瞻性负荷试验的医疗保险患者的死亡率。
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):309-14. doi: 10.1161/CIRCOUTCOMES.113.000138. Epub 2013 May 14.